Copyright
©2005 Baishideng Publishing Group Inc.
World J Gastroenterol. Feb 28, 2005; 11(8): 1220-1224
Published online Feb 28, 2005. doi: 10.3748/wjg.v11.i8.1220
Published online Feb 28, 2005. doi: 10.3748/wjg.v11.i8.1220
Figure 1 Tumor volumes (mean±SE) in BALB/c mice with hepatoma treated with sodium chloride (control, ◆, n = 5), non-CpG ODN (□, n = 5), CpG ODN (◇, n = 8), 5-FU (▲, n = 8) and 5-FU combined with CpG ODN (○, n = 8).
Figure 2 The serum levels of IL-12 and IFN-γ (mean±SE) in BALB/c mice with hepatoma after different treatments.
Peripheral blood was collected from mice with tumor 24 h after the final injection of sodium chloride (control, n = 5), non-CpG ODN (n = 5), CpG ODN (n = 8), 5-FU (n = 8) and 5-FU combined with CpG ODN (n = 8). ODNs IL-12 and IFN-γ contents in sera were assayed with ELISA.
- Citation: Wang XS, Sheng Z, Ruan YB, Guang Y, Yang ML. CpG oligodeoxynucleotides inhibit tumor growth and reverse the immunosuppression caused by the therapy with 5-fluorouracil in murine hepatoma. World J Gastroenterol 2005; 11(8): 1220-1224
- URL: https://www.wjgnet.com/1007-9327/full/v11/i8/1220.htm
- DOI: https://dx.doi.org/10.3748/wjg.v11.i8.1220